Driving Discovery: Expanded Facilities Faster Innovation

Concept Life Sciences is proud to announce the official opening of its newly expanded integrated drug discovery facilities at its Chapel-en-le-Frith headquarters to establish one of the UKs largest drug discovery research sites.

Now home to 130 scientists, the expansion brings chemistry, ADMET, and screening biology under one roof, significantly enhancing the company’s ability to deliver faster, more efficient and fully integrated drug discovery solutions, empowering customers with a seamless path from concept to clinic.

"This expansion strengthens our ability to turn breakthrough science into viable, fundable, and clinically impactful therapies,” said Jonathan Critchley, Chief Financial Officer. “We offer bespoke, solution-oriented approaches that empower early-stage research companies to overcome the unique challenges of drug discovery.”

Commenting on the opening, Jon Pearce MP, High Peak said ""It is fantastic to see Concept Life Sciences investing in Chapel-en-le-Frith and creating one of the UK’s leading drug discovery research sites here in High Peak. This expansion not only brings high-skilled, high-value jobs to our community, but also puts our region at the forefront of groundbreaking work to develop life-changing therapies."

With expanded capabilities across multiple modalities - including small molecules, biologics, peptides, and cell & gene therapies - customers will additionally benefit from:

• Faster development timelines (as little as 32 months to clinic)
• Streamlined communication with cross-functional teams in one location
• Bespoke solutions tailored to complex scientific challenges
• Improved success rates for early-stage innovations

With cutting-edge facilities and a client-centric approach, Concept Life Sciences continues to drive innovation in drug discovery. The expanded site is a testament to the company’s commitment to transforming science into therapies that improve lives worldwide.

‍